• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

裂谷热病毒MP-12疫苗在培养细胞中连续传代期间的遗传稳定性

Genetic stability of Rift Valley fever virus MP-12 vaccine during serial passages in culture cells.

作者信息

Lokugamage Nandadeva, Ikegami Tetsuro

机构信息

Department of Pathology, The University of Texas Medical Branch at Galveston, 301 University Blvd. Galveston, Texas 77555 USA.

The Sealy Center for Vaccine Development, The University of Texas Medical Branch at Galveston, 301 University Blvd. Galveston, Texas 77555 USA.

出版信息

NPJ Vaccines. 2017;2. doi: 10.1038/s41541-017-0021-9. Epub 2017 Jul 17.

DOI:10.1038/s41541-017-0021-9
PMID:29167748
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5627234/
Abstract

Rift Valley fever (RVF) is a mosquito-borne zoonotic disease endemic to Africa which affects both ruminants and humans. RVF causes serious damage to the livestock industry and is also a threat to public health. The Rift Valley fever virus has a segmented negative-stranded RNA genome consisting of Large (L)-, Medium (M)-, and Small (S)-segments. The live-attenuated MP-12 vaccine is immunogenic in livestock and humans, and is conditionally licensed for veterinary use in the U.S. The MP-12 strain encodes 23 mutations (nine amino acid substitutions) and is attenuated through a combination of mutations in the L-, M-, and S-segments. Among them, the M-U795C, M-A3564G, and L-G3104A mutations contribute to viral attenuation through the L- and M-segments. The M-U795C, M-A3564G, L-U533C, and L-G3750A mutations are also independently responsible for temperature-sensitive (ts) phenotype. We hypothesized that a serial passage of the MP-12 vaccine in culture cells causes reversions of the MP-12 genome. The MP-12 vaccine and recombinant rMP12-ΔNSs16/198 were serially passaged 25 times. Droplet digital PCR analysis revealed that the reversion occurred at L-G3750A during passages of MP-12 in Vero or MRC-5 cells. The reversion also occurred at M-A3564G and L-U533C of rMP12-ΔNSs16/198 in Vero cells. Reversion mutations were not found in MP-12 or the variant, rMP12-TOSNSs, in the brains of mice with encephalitis. This study characterized genetic stability of the MP-12 vaccine and the potential risk of reversion mutation at the L-G3750A ts mutation after excessive viral passages in culture cells.

摘要

裂谷热(RVF)是一种由蚊子传播的人畜共患病,在非洲流行,会影响反刍动物和人类。裂谷热对畜牧业造成严重损害,也对公共卫生构成威胁。裂谷热病毒具有分段的负链RNA基因组,由大(L)、中(M)和小(S)片段组成。减毒活疫苗MP-12在牲畜和人类中具有免疫原性,在美国有条件地被许可用于兽医用途。MP-12毒株编码23个突变(9个氨基酸替换),并通过L、M和S片段中的突变组合而减毒。其中,M-U795C、M-A3564G和L-G3104A突变通过L和M片段导致病毒减毒。M-U795C、M-A3564G、L-U533C和L-G3750A突变也独立导致温度敏感(ts)表型。我们假设MP-12疫苗在培养细胞中连续传代会导致MP-12基因组的回复突变。MP-12疫苗和重组rMP12-ΔNSs16/198连续传代25次。液滴数字PCR分析显示,MP-12在Vero或MRC-5细胞传代过程中,L-G3750A发生了回复突变。rMP12-ΔNSs16/198在Vero细胞中的M-A3564G和L-U533C也发生了回复突变。在患有脑炎的小鼠大脑中,MP-12或变体rMP12-TOSNSs中未发现回复突变。本研究表征了MP-12疫苗的遗传稳定性以及在培养细胞中病毒过度传代后L-G3750A ts突变处回复突变的潜在风险。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80d8/5627234/5f0d3acce44d/41541_2017_21_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80d8/5627234/81d7d6cd8b4f/41541_2017_21_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80d8/5627234/5ede92a10e3a/41541_2017_21_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80d8/5627234/ce2d3907dde1/41541_2017_21_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80d8/5627234/1cce3ccf2fe2/41541_2017_21_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80d8/5627234/aadbe132831b/41541_2017_21_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80d8/5627234/5f0d3acce44d/41541_2017_21_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80d8/5627234/81d7d6cd8b4f/41541_2017_21_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80d8/5627234/5ede92a10e3a/41541_2017_21_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80d8/5627234/ce2d3907dde1/41541_2017_21_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80d8/5627234/1cce3ccf2fe2/41541_2017_21_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80d8/5627234/aadbe132831b/41541_2017_21_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/80d8/5627234/5f0d3acce44d/41541_2017_21_Fig6_HTML.jpg

相似文献

1
Genetic stability of Rift Valley fever virus MP-12 vaccine during serial passages in culture cells.裂谷热病毒MP-12疫苗在培养细胞中连续传代期间的遗传稳定性
NPJ Vaccines. 2017;2. doi: 10.1038/s41541-017-0021-9. Epub 2017 Jul 17.
2
Rift Valley Fever Virus MP-12 Vaccine Is Fully Attenuated by a Combination of Partial Attenuations in the S, M, and L Segments.裂谷热病毒MP-12疫苗通过S、M和L基因片段的部分减毒组合而完全减毒。
J Virol. 2015 Jul;89(14):7262-76. doi: 10.1128/JVI.00135-15. Epub 2015 May 6.
3
The L, M, and S Segments of Rift Valley Fever Virus MP-12 Vaccine Independently Contribute to a Temperature-Sensitive Phenotype.裂谷热病毒MP - 12疫苗的L、M和S片段独立促成温度敏感表型。
J Virol. 2016 Jan 27;90(7):3735-44. doi: 10.1128/JVI.02241-15.
4
Risk analysis of inter-species reassortment through a Rift Valley fever phlebovirus MP-12 vaccine strain.通过裂谷热静脉病毒MP-12疫苗株进行种间重配的风险分析。
PLoS One. 2017 Sep 19;12(9):e0185194. doi: 10.1371/journal.pone.0185194. eCollection 2017.
5
Attenuation and protective efficacy of Rift Valley fever phlebovirus rMP12-GM50 strain.裂谷热病毒 rMP12-GM50 株的衰减和保护效力。
Vaccine. 2017 Dec 4;35(48 Pt B):6634-6642. doi: 10.1016/j.vaccine.2017.10.036. Epub 2017 Oct 20.
6
Characterization of Rift Valley fever virus MP-12 strain encoding NSs of Punta Toro virus or sandfly fever Sicilian virus.裂谷热病毒 MP-12 株编码蓬塔托罗病毒或致热西尼罗河病毒 NSs 的特性。
PLoS Negl Trop Dis. 2013 Apr 18;7(4):e2181. doi: 10.1371/journal.pntd.0002181. Print 2013.
7
Temperature-sensitive mutations for live-attenuated Rift Valley fever vaccines: implications from other RNA viruses.用于减毒活裂谷热疫苗的温度敏感突变:来自其他RNA病毒的启示
Front Microbiol. 2015 Aug 11;6:787. doi: 10.3389/fmicb.2015.00787. eCollection 2015.
8
Rift Valley fever virus MP-12 vaccine encoding Toscana virus NSs retains neuroinvasiveness in mice.裂谷热病毒 MP-12 疫苗编码的托斯卡纳病毒 NSs 在小鼠中保留神经侵袭性。
J Gen Virol. 2013 Jul;94(Pt 7):1441-1450. doi: 10.1099/vir.0.051250-0. Epub 2013 Mar 20.
9
Attenuation of pathogenic Rift Valley fever virus strain through the chimeric S-segment encoding sandfly fever phlebovirus NSs or a dominant-negative PKR.通过编码白蛉热静脉病毒NSs或显性负性PKR的嵌合S片段减弱致病性裂谷热病毒株
Virulence. 2016 Nov 16;7(8):871-881. doi: 10.1080/21505594.2016.1195528. Epub 2016 Jun 1.
10
Rift Valley fever vaccines: an overview of the safety and efficacy of the live-attenuated MP-12 vaccine candidate.裂谷热疫苗:减毒活疫苗候选株MP-12的安全性与有效性概述
Expert Rev Vaccines. 2017 Jun;16(6):601-611. doi: 10.1080/14760584.2017.1321482. Epub 2017 May 2.

引用本文的文献

1
The Temperature-Associated Effects of Rift Valley Fever Virus Infections in Mosquitoes and Climate-Driven Epidemics: A Review.裂谷热病毒感染蚊子的温度相关影响及气候驱动的疫情:综述
Viruses. 2025 Feb 1;17(2):217. doi: 10.3390/v17020217.
2
Genome characterization of Rift Valley fever virus isolated from cattle, goats and sheep during interepidemic periods in Kenya.肯尼亚间疫情期从牛、山羊和绵羊中分离的裂谷热病毒的基因组特征。
BMC Vet Res. 2024 Aug 23;20(1):376. doi: 10.1186/s12917-024-04161-1.
3
Vaccine strains of Rift Valley fever virus exhibit attenuation at the maternal-fetal placental interface.

本文引用的文献

1
Vaccination of alpacas against Rift Valley fever virus: Safety, immunogenicity and pathogenicity of MP-12 vaccine.羊驼接种裂谷热病毒疫苗:MP - 12疫苗的安全性、免疫原性和致病性
Vaccine. 2017 Jan 23;35(4):655-662. doi: 10.1016/j.vaccine.2016.12.003. Epub 2016 Dec 21.
2
Safety and Efficacy Profile of Commercial Veterinary Vaccines against Rift Valley Fever: A Review Study.抗裂谷热商业兽用疫苗的安全性和有效性概况:一项综述研究。
J Immunol Res. 2016;2016:7346294. doi: 10.1155/2016/7346294. Epub 2016 Sep 4.
3
Reversion of Cold-Adapted Live Attenuated Influenza Vaccine into a Pathogenic Virus.
裂谷热病毒的疫苗株在母胎胎盘界面表现出减毒特性。
J Virol. 2024 Aug 20;98(8):e0098324. doi: 10.1128/jvi.00983-24. Epub 2024 Jul 17.
4
Vaccine strains of Rift Valley fever virus exhibit attenuation at the maternal-fetal placental interface.裂谷热病毒的疫苗株在母胎胎盘界面表现出减毒特性。
bioRxiv. 2024 Jun 1:2024.05.31.596800. doi: 10.1101/2024.05.31.596800.
5
Computer-Selected Antiviral Compounds: Assessing In Vitro Efficacies against Rift Valley Fever Virus.计算机筛选的抗病毒化合物:评估对裂谷热病毒的体外疗效。
Viruses. 2024 Jan 5;16(1):88. doi: 10.3390/v16010088.
6
Multifunctional human monoclonal antibody combination mediates protection against Rift Valley fever virus at low doses.多功能人源单克隆抗体组合以低剂量介导对裂谷热病毒的保护。
Nat Commun. 2023 Sep 13;14(1):5650. doi: 10.1038/s41467-023-41171-3.
7
Perspectives of Next-Generation Live-Attenuated Rift Valley Fever Vaccines for Animal and Human Use.用于动物和人类的下一代减毒活裂谷热疫苗的前景
Vaccines (Basel). 2023 Mar 21;11(3):707. doi: 10.3390/vaccines11030707.
8
Evaluations of rationally designed rift valley fever vaccine candidate RVax-1 in mosquito and rodent models.在蚊子和啮齿动物模型中对合理设计的裂谷热疫苗候选物RVax-1进行评估。
NPJ Vaccines. 2022 Sep 21;7(1):109. doi: 10.1038/s41541-022-00536-3.
9
Identification of Single Amino Acid Changes in the Rift Valley Fever Virus Polymerase Core Domain Contributing to Virus Attenuation .鉴定裂谷热病毒聚合酶核心结构域中单个氨基酸变化对病毒减毒的影响。
Front Cell Infect Microbiol. 2022 Apr 28;12:875539. doi: 10.3389/fcimb.2022.875539. eCollection 2022.
10
Development of a Simian RNA Polymerase I Promoter-Driven Reverse Genetics for the Rescue of Recombinant Rift Valley Fever Virus from Vero Cells.用于从Vero细胞拯救重组裂谷热病毒的猿猴RNA聚合酶I启动子驱动的反向遗传学技术的开发
J Virol. 2021 Mar 10;95(7). doi: 10.1128/JVI.02004-20. Epub 2021 Jan 13.
冷适应减毒活流感疫苗回复为致病病毒
J Virol. 2016 Sep 12;90(19):8454-63. doi: 10.1128/JVI.00163-16. Print 2016 Oct 1.
4
Rift Valley fever virus NSs protein functions and the similarity to other bunyavirus NSs proteins.裂谷热病毒NSs蛋白的功能及其与其他布尼亚病毒NSs蛋白的相似性。
Virol J. 2016 Jul 2;13:118. doi: 10.1186/s12985-016-0573-8.
5
Mutational Analysis of the Rift Valley Fever Virus Glycoprotein Precursor Proteins for Gn Protein Expression.用于Gn蛋白表达的裂谷热病毒糖蛋白前体蛋白的突变分析
Viruses. 2016 May 24;8(6):151. doi: 10.3390/v8060151.
6
Application of Droplet Digital PCR to Validate Rift Valley Fever Vaccines.应用液滴数字PCR技术验证裂谷热疫苗
Methods Mol Biol. 2016;1403:207-20. doi: 10.1007/978-1-4939-3387-7_10.
7
The L, M, and S Segments of Rift Valley Fever Virus MP-12 Vaccine Independently Contribute to a Temperature-Sensitive Phenotype.裂谷热病毒MP - 12疫苗的L、M和S片段独立促成温度敏感表型。
J Virol. 2016 Jan 27;90(7):3735-44. doi: 10.1128/JVI.02241-15.
8
Safety and immunogenicity of a mutagenized, live attenuated Rift Valley fever vaccine, MP-12, in a Phase 1 dose escalation and route comparison study in humans.一种经诱变的裂谷热减毒活疫苗MP-12在人体1期剂量递增和途径比较研究中的安全性和免疫原性。
Vaccine. 2016 Jan 20;34(4):424-429. doi: 10.1016/j.vaccine.2015.12.030. Epub 2015 Dec 22.
9
Rift Valley fever MP-12 vaccine Phase 2 clinical trial: Safety, immunogenicity, and genetic characterization of virus isolates.裂谷热MP - 12疫苗2期临床试验:病毒分离株的安全性、免疫原性及基因特征
Vaccine. 2016 Jan 20;34(4):523-530. doi: 10.1016/j.vaccine.2015.11.078. Epub 2015 Dec 17.
10
Evaluation of the Efficacy, Potential for Vector Transmission, and Duration of Immunity of MP-12, an Attenuated Rift Valley Fever Virus Vaccine Candidate, in Sheep.减毒裂谷热病毒候选疫苗MP-12在绵羊中的效力、媒介传播潜力及免疫持续时间评估
Clin Vaccine Immunol. 2015 Aug;22(8):930-7. doi: 10.1128/CVI.00114-15. Epub 2015 Jun 3.